Tackling vaccine hyporesponsiveness through global collaboration, diverse population studies, and data integration.
Saved in:
| Title: | Tackling vaccine hyporesponsiveness through global collaboration, diverse population studies, and data integration. |
|---|---|
| Authors: | Amoah AS; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands. Electronic address: a.s.amoah@lumc.nl., Agnandji ST; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon; Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany; Institute of Medical Microbiology, University Hospital Münster, Münster, Germany., Bengtson M; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Downs JA; Center for Global Health, Weill Cornell Medicine, New York City, NY, USA; Department of Medicine, Weill Bugando School of Medicine, Mwanza, Tanzania., Esen M; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon; Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany; Cluster of Excellence EXC 2124: Controlling Microbes to Fight Infections, Tübingen, Germany., Giddaluru J; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Jochems SP; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Kaisar MMM; Master of Biomedicine Programme, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Department of Parasitology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia., Makinde J; Department of Infectious Disease, Faculty of Medicine, Imperial College, London, UK; ManteisBio, London, UK., Manurung MD; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Mbow M; Department of Immunology, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar, Senegal; Institute for Health Research, Epidemiological Surveillance and Training (IRESSEF), Dakar, Senegal., Moncunill G; ISGlobal, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Barcelona, Spain., Murugan R; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Mutai J; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, USA; Center for Geographic Medicine Research-Coast, Kenya Medical Research Institute, Kilifi, Kenya., Nakaya HI; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Nkurunungi G; Immunomodulation and Vaccines Group, Vaccine Research Theme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Palmblad M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands., Pyuza JJ; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands; Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania; School of Public Health, KCMC University, Moshi, Tanzania., Stam KA; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., de Steenhuijsen Piters WAA; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Walusimbi B; Immunomodulation and Vaccines Group, Vaccine Research Theme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Yazdanbakhsh M; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands. |
| Corporate Authors: | Participants of the Lorentz Center Workshop titled Connecting people to reverse vaccine hyporesponsiveness |
| Source: | The Lancet. Microbe [Lancet Microbe] 2026 Jan; Vol. 7 (1), pp. 101263. Date of Electronic Publication: 2025 Nov 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
